Overview

RAD BioMed is a success-accelerator for Israeli life science startups.
With state-of-the-art facilities, an entrepreneurial team of experts and broad contact networks, RAD BioMed incubates startups at various stages in the medical devices, biopharma and diagnostic sectors.

Our overriding goal is to help entrepreneurs successfully navigate turbulent start-up waters and empower innovation. We do this by ‘de-risking’ the start-up process with comprehensive support to turn breakthrough concepts into commercial products.

Starting at the concept-stage, we identify scientists with big dreams and help them to dream bigger. We provide the framework they need to succeed, including funding, mentoring, umbrella business development, marketing, HR and administration services and state-of-the-art facilities. The result: minimum time to maximum value.

RAD BioMed is owned by Mr. Yehuda Zisapel and Professor Nava Zisapel, among Israel’s most successful start-up investors. Their reputations and the depth and effectiveness of our process have earned us the trust of global co-investors and business development partners, who view our pre-screened, well-managed startups as a reduced-risk opportunity to benefit from Israel’s exciting life science achievements.